Results confirm accuracy of DecisionDx-Melanoma to identify recurrence risk; A second independent, prospective study confirms test accuracy
Category Archives: AZBio News
BIO survey to support PDUFA 6 negotiations
Please take a few minutes to log in to BIO’s FDA survey and provide feedback on your company’s interactions with FDA.Continue reading
C-Path and CDISC Announce Updated Therapeutic Area Standard for TB
The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the open availability of an updated CDISC Therapeutic Area (TA) Standard for tuberculosis (TB). The tuberculosis v2.0 standard is an updated version of the original TB v1.0 standard and includes new content focused on pediatrics and drug susceptibility testing.Continue reading
Systems Imagination partners with Macrogen Corp. to provide superior genomic data generation and integrated analytical services.
Systems Imagination (SII), a knowledge evolution company, announced today a partnership with Macrogen Corp. of Rockville, Maryland, the integrated genomic service provider and precision medicine biotechnology company.Continue reading
CTCA Western clinical research director authors five innovative studies presented at ASCO
Dr. Glen Weiss is a Translational Physician Scientist (TPS) with a joint appointment at TGen and Cancer Treatment Centers of America. He is board certified in internal medicine and medical oncology. He is currently Co-Head of the Lung Cancer Unit and Clinical Associate Professor at TGen, Director of Clinical Research at Cancer Treatment Centers of America, and holds a Clinical Assistant Professor of Medicine appointment at the University of Arizona College of Medicine-Phoenix.Continue reading
VisionGate Hires Renowned Chief Medical Officer Dr. Javier Zulueta
PHOENIX, Ariz. (June 2, 2016) – VisionGate, Inc. today announced the appointment of Dr. Javier Zulueta as its Chief Medical Officer. A world-renowned pulmonologist, professor and 16-year Director of Pulmonary Service at the University Clinic of Navarra, the teaching hospital of Spain’s University of Navarra School of Medicine, Dr. Zulueta will provide expert counsel and oversight of VisionGate’s clinical collaborations and associated clinical trials in lung cancer early detection and chemoprevention therapy.Continue reading
UA Engineers Zero In on Ovarian Cancer
Jennifer Barton is identifying biomarkers and creating optical imaging tools to screen for a form of cancer often called a “silent killer” of women.Continue reading
Spring 2016 Arizona Innovation Challenge Finalists Announced
The Spring 2016 round of the Arizona Innovation Challenge (AIC) continues as the Arizona Commerce Authority (ACA) announced 10 finalists in its bi-annual business plan competition.
VisionGate’s LuCED® Test and New Drug Therapy to Prevent Lung Cancer Demonstrate Promise in National Surveys of Pulmonologists
Independent Research Group Validates Market Demand of VisionGate’s Two ProductsContinue reading
TGen investigates global fungal threat; discovers six new species associated with bat evolution
Histoplasma infection poses deadly risk to HIV and other immune-compromised patientsContinue reading